Skip to main content

1st Precision Medicine in Immuno-Oncology Meeting

Translation Research in Immuno-Oncology

The success of recent, immune-based cancer therapies in generating durable responses in patients across multiple indications has been groundbreaking.
Nevertheless, not all patients respond to such therapies.
Development of predictive biomarkers to assess the likelihood of patient response prior to initiation of therapy is of increasing importance to patients, payers, and regulators.
Issues and examples of work in this domain will be provided in this meting.

Júlio Oliveira
Lúcio Santos

* Registration Deadline: June 29, 2017
** Pre-Meeting Course with limited space available


Maria Augusta Guimarães

We welcome you to the meeting 1st Precision Medicine in Immuno-Oncology that has been organized by IPO Immunology Department and IPO-Porto Research Center throught the group of Pathology and Experimental Therapy.
The Immuno-Oncology is a way to gather acknowlegment among Doctors, Investigators and Laboratory Technicians
All IPO Departments involved in this kind of therapies strongly participated on the organization of this event.
We wish you a pleasant two days meeting at IPO-Porto.

Scientific Program

Gabriela Martins

Graça Braz

Júlio Oliveira

Lúcio Lara Santos

António Campos Júnior

Armando Pinto

Catarina Pinho

Cristina Gaiteiro

Gabriela Martins

Graça Braz

Inês Godinho

Júlio Oliveira

Lúcio Santos

Maria Augusta Guimarães

Susana Roncon





Instituto Português Oncologia do Porto Francisco Gentil, EPE

IPO – Porto

4200-072 Porto

Ligia Silva

(+351) 914 592 380

Jorge Pimentel

(+351) 914 592 380